These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17252917)

  • 1. [Epidemiology of myasthenia gravis].
    Pekmezović T; Lavrnić D; Jarebinski M; Apostolski S
    Srp Arh Celok Lek; 2006; 134(9-10):453-6. PubMed ID: 17252917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of myasthenia gravis.
    Phillips LH
    Semin Neurol; 2004 Mar; 24(1):17-20. PubMed ID: 15229788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.
    Alshekhlee A; Miles JD; Katirji B; Preston DC; Kaminski HJ
    Neurology; 2009 May; 72(18):1548-54. PubMed ID: 19414721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of myasthenia gravis in Antioquia, Colombia].
    Sánchez JL; Uribe CS; Franco AF; Jiménez ME; Arcos-Burgos OM; Palacio LG
    Rev Neurol; 2002 Jun 1-15; 34(11):1010-2. PubMed ID: 12134295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
    Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological study of adult-onset myasthenia gravis in the area of Belgrade (Serbia) in the period 1979-2008.
    Lavrnic D; Basta I; Rakocevic-Stojanovic V; Stevic Z; Peric S; Nikolic A; Marjanovic I; Pekmezovic T
    Neuroepidemiology; 2013; 40(3):190-4. PubMed ID: 23363926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of seropositive myasthenia gravis in Cape Town and South Africa.
    Bateman KJ; Schinkel M; Little F; Liebenberg L; Vincent A; Heckmann JM
    S Afr Med J; 2007 Oct; 97(10):959-62. PubMed ID: 18000579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992).
    Lavrnić D; Jarebinski M; Rakocević-Stojanović V; Stević Z; Lavrnić S; Pavlović S; Trikić R; Tripković I; Nesković V; Apostolski S
    Acta Neurol Scand; 1999 Sep; 100(3):168-74. PubMed ID: 10478580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years.
    Pallaver F; Riviera AP; Piffer S; Ricciardi R; Roni R; Orrico D; Bonifati DM
    Neuroepidemiology; 2011; 36(4):282-7. PubMed ID: 21757957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
    Somnier FE
    Neurology; 2005 Sep; 65(6):928-30. PubMed ID: 16186537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of myasthenia gravis in central and western Virginia.
    Phillips LH; Torner JC; Anderson MS; Cox GM
    Neurology; 1992 Oct; 42(10):1888-93. PubMed ID: 1407568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of myasthenia gravis in the province of Ferrara: a community-based study.
    Casetta I; Fallica E; Govoni V; Azzini C; Tola M; Granieri E
    Neuroepidemiology; 2004; 23(6):281-4. PubMed ID: 15297794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of seropositive myasthenia gravis in Greece.
    Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national epidemiological study of Myasthenia Gravis in Australia.
    Gattellari M; Goumas C; Worthington JM
    Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of myasthenia gravis in Ontario, Canada.
    Breiner A; Widdifield J; Katzberg HD; Barnett C; Bril V; Tu K
    Neuromuscul Disord; 2016 Jan; 26(1):41-6. PubMed ID: 26573434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myasthenia gravis: treatments and remissions].
    Dunand M; Lalive PH; Vokatch N; Kuntzer T
    Rev Med Suisse; 2007 May; 3(110):1185-6, 1188-90. PubMed ID: 17564346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Myasthenia Gravis in Slovakia in the Years 1977-2015.
    Martinka I; Fulova M; Spalekova M; Spalek P
    Neuroepidemiology; 2018; 50(3-4):153-159. PubMed ID: 29558746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic problems in patients with myasthenia gravis].
    Lavrnić D; Rakocević-Stojanović V; Tripković I; Pavlović S; Stević Z; Trikić R; Nesković V; Apostolski S
    Srp Arh Celok Lek; 2000; 128(7-8):247-52. PubMed ID: 11089431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on myasthenia gravis.
    Thanvi BR; Lo TC
    Postgrad Med J; 2004 Dec; 80(950):690-700. PubMed ID: 15579606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult onset acquired myasthenia gravis in three Great Dane littermates.
    Kent M; Glass EN; Acierno M; Shelton GD
    J Small Anim Pract; 2008 Dec; 49(12):647-50. PubMed ID: 18684140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.